[HTML][HTML] Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression …
ZY Liu, XH Lin, HY Guo, X Shi, DY Zhang… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and …
ZY Liu, XH Lin, HY Guo, X Shi… - International …, 2024 - pubmed.ncbi.nlm.nih.gov
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and …
ZY Liu, XH Lin, HY Guo, X Shi, DY Zhang… - … Journal of Biological …, 2024 - europepmc.org
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
[HTML][HTML] Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression …
ZY Liu, XH Lin, HY Guo, X Shi, DY Zhang… - International Journal of …, 2024 - ijbs.com
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various
pathological conditions, including cancer. However, a systematic evaluation of ALDH …
pathological conditions, including cancer. However, a systematic evaluation of ALDH …